BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8334939)

  • 21. [Nedaplatin and 5-fluorouracil combined with radiotherapy for advanced esophageal cancer].
    Nakamura T; Ide H; Eguchi R; Hayashi K; Ota M; Narumiya K; Takasaki K; Mitsuhashi M
    Gan To Kagaku Ryoho; 2003 Jun; 30(6):803-7. PubMed ID: 12852347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Esophageal cancer: outcomes of surgery, neoadjuvant chemotherapy, and three-dimension conformal radiotherapy.
    Fréchette E; Buck DA; Kaplan BJ; Chung TD; Shaw JE; Kachnic LA; Neifeld JP
    J Surg Oncol; 2004 Aug; 87(2):68-74. PubMed ID: 15282698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Concurrent concentrated radio-chemotherapy of epidermoid cancer of the esophagus. Long-term results of a phase II national multicenter trial in 122 non-operable patients (FFCD 8803)].
    Seitz JF; Milan C; Giovannini M; Dumas F; Cauvin JM; Conroy T; François E; Renard P; Votte-Lambert A; Paillot B; Bedenne L; ;
    Gastroenterol Clin Biol; 2000 Feb; 24(2):201-10. PubMed ID: 12687962
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is extended volume external beam radiation therapy covering the anastomotic site beneficial in post-esophagectomy high risk patients?
    Yu E; Dar R; Rodrigues GB; Stitt L; Videtic GM; Truong P; Tomiak A; Ash R; Brecevic E; Inculet R; Malthaner R; Vincent M; Craig I; Kocha W; Lefcoe M
    Radiother Oncol; 2004 Nov; 73(2):141-8. PubMed ID: 15542160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Observation on therapeutic effect of electroacupuncture combined with Chinese herbs for treatment of prolapse of lumbar intervertebral disc of yang deficiency and cold coagulation type].
    Liu L; Liu LG; Lü M; Ran WJ
    Zhongguo Zhen Jiu; 2009 Aug; 29(8):626-8. PubMed ID: 19947265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined-modality therapy for esophageal cancer: phase I trial of escalating doses of paclitaxel in combination with cisplatin, 5-fluorouracil, and high-dose radiation before esophagectomy.
    Weiner LM; Colarusso P; Goldberg M; Dresler C; Coia LR
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-93-S19-95. PubMed ID: 9427276
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Study of the antitoxic function of the liver using 131I-sodium benzoate in esophageal cancer].
    Kanaf'ianov GS; Karataev KM; Azhigaliev NA
    Med Radiol (Mosk); 1984 Mar; 29(3):24-6. PubMed ID: 6700396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Swallowing function and weight change observed in a phase I/II study of external-beam radiation, brachytherapy and concurrent chemotherapy in localized cancer of the esophagus (RTOG 9207).
    Gaspar LE; Winter K; Kocha WI; Pinover WH; Herskovic ; Graham M; Gunderson L
    Cancer J; 2001; 7(5):388-94. PubMed ID: 11693897
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of esophagogastroscopy in application and follow-up of high-dose-rate brachytherapy (HDRB) for treatment of esophageal carcinoma.
    Greene FL; Boulware RJ; Bianco J
    Surg Laparosc Endosc; 1995 Dec; 5(6):425-30. PubMed ID: 8611986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Esophageal cancer. A prospective phase II study of concomitant-boost external-beam chemoradiation with a top-up endoluminal boost.
    Brunner TB; Rupp A; Melzner W; Grabenbauer GG; Sauer R
    Strahlenther Onkol; 2008 Jan; 184(1):15-22. PubMed ID: 18188518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Concurrent chemotherapy and radiation therapy for unresectable locally advanced carcinoma of the esophagus. Phase II study and clinical review on literature].
    Fritz P; Stoll P; Wannenmacher M; Zierhut D
    Strahlenther Onkol; 2003 May; 179(5):328-36. PubMed ID: 12740660
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Simultaneous radiochemotherapy and endoluminal HDR brachytherapy in esophageal cancer].
    Patonay P; Naszály A; Mayer A
    Strahlenther Onkol; 2007 Feb; 183(2):94-8. PubMed ID: 17294114
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Long-term results of chemoradiation therapy for the patients with locally advanced (T4) esophageal cancer].
    Sekikawa K; Onogi H; Yazawa T; Sato Y; Sakamoto W; Miyamoto K; Fujita S; Suzuki S; Endo Y; Ohki S; Takenoshita S
    Gan To Kagaku Ryoho; 2006 Sep; 33(9):1253-6. PubMed ID: 16969020
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical observation on treatment of colonic cancer with combined treatment of chemotherapy and Chinese herbal medicine.
    Zhou LY; Shan ZZ; You JL
    Chin J Integr Med; 2009 Apr; 15(2):107-11. PubMed ID: 19407947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Intracavitary brachytherapy in esophageal neoplasms. Experience at the Radiology Institute of Brescia].
    La Face B; Micheletti E; Baroncelli G; Catalano G; Huscher A; Cestari R; Ravelli P; Verzelletti L; Galelli M
    Radiol Med; 1997 May; 93(5):607-12. PubMed ID: 9280947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase I trial of combined-modality therapy for localized esophageal cancer: escalating doses of continuous-infusion paclitaxel with cisplatin and concurrent radiation therapy.
    Brenner B; Ilson DH; Minsky BD; Bains MS; Tong W; Gonen M; Kelsen DP
    J Clin Oncol; 2004 Jan; 22(1):45-52. PubMed ID: 14701767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment results of chemoradiotherapy for clinical stage I (T1N0M0) esophageal carcinoma.
    Yamada K; Murakami M; Okamoto Y; Okuno Y; Nakajima T; Kusumi F; Takakuwa H; Matsusue S
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1106-11. PubMed ID: 16504758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Preliminary clinical evaluation of continuous infusion of 5-FU and low-dose Cisplatin (LFP) therapy alone and combined with radiation therapy for treatment of advanced or recurrent esophageal cancer].
    Itoh S; Morita S; Ohnishi T; Tsuji A; Takamatsu M; Horimi T
    Gan To Kagaku Ryoho; 2002 Feb; 29(2):233-8. PubMed ID: 11865629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective study of external radiotherapy with and without intraluminal brachytherapy for esophageal cancer in Japan. JASTRO Study Group.
    Okawa T
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():301-6. PubMed ID: 10895171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined brachytherapy with external beam radiotherapy for localized prostate cancer: reduced morbidity with an intraoperative brachytherapy planning technique and supplemental intensity-modulated radiation therapy.
    Zelefsky MJ; Nedelka MA; Arican ZL; Yamada Y; Cohen GN; Shippy AM; Park JJ; Zaider M
    Brachytherapy; 2008; 7(1):1-6. PubMed ID: 18299108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.